News

Dr Mazzo brings to Regado almost 25 years of experience in the pharmaceutical industry, most recently as president and CEO of Aeterna Zentaris. Dr Mazzo earned a bachelor

As part of the agreement, Abingdon will provide clinical and regulatory services for Stason’s pipeline of potential drug candidates and devices in the areas of cancer and inflammation.

The product will be manufactured by Alkermes and commercialized by Janssen-Cilag, an affiliate company of Cilag International. Alkermes and Cilag have previously announced an exclusive agreement to commercialize

Under the terms of the settlement, Inhibitex agreed to pay Nabi a total of $2.2 million, $1.7 million in connection with the execution of settlement and $0.5 million

Through GeneWize, its wholly owned subsidiary, GeneLink has successfully launched the first direct selling industry company to focus exclusively on marketing nutritional supplements and skin care products specifically

According to the company, the PhenoSense integrase assay directly measures the susceptibility of HIV to a new and potent class of integrase inhibitor drugs that blocks viral replication

Under the agreement, Patent Profit International (PPI) will market Health Discovery’s (HDC) patent portfolio, which includes exclusive rights to support vector machine techniques and applications that reach far

Payment of the milestone announced was triggered upon Shire’s net sales of Daytrana exceeding $75 million in the 12-months preceding June 30, 2008. Under Noven’s agreement with Shire,

Cook Medical’s products are said to be designed specifically to provide increased flexibility and improved conformability in the aorta and iliac artery, a tortuous section of patient anatomy,